外科住院医疗安全:队列研究
该多中心回顾性队列研究纳入美国11家医院2018年收治的1009例成人外科手术患者,采用触发工具结合电子健康记录全面审查评估围手术期住院不良事件。结果显示不良事件发生率为38.0%(95%CI 32.6–43.4),重大不良事件为15.9%(95%CI 12.7–19.0);593起事件中59.5%潜在可预防,20.7%为确定或很可能可预防。最常见为手术操作相关事件(49.3%),其次为药物不良事件(26.6%)和医疗相关感染(12.4%)。作者认为结果强调围手术期全程所有卫生专业人员持续改进患者安全的必要性。
要点
- 1009例外科住院患者中不良事件发生率38.0%(95%CI 32.6–43.4),重大不良事件15.9%(95%CI 12.7–19.0)。
- 593起不良事件中353起(59.5%)潜在可预防,123起(20.7%)为确定或很可能可预防。
- 最常见不良事件为手术操作相关(292起,49.3%),其次为药物不良事件(158起,26.6%)、医疗相关感染(74起,12.4%)。
- 不良事件最常见于普通病房(289起,48.8%),其次为手术室(155起,26.1%)和重症监护病房(77起,13.0%)。
- 涉及职业以主治医师最多(531起,89.5%),其次为护士(349起,58.9%)和住院医师(294起,49.5%)。
适用人群与场景
- 2018年因手术入院的成人患者,从64 121例成人中随机抽取1009例。
- 场景为美国11家医院的围手术期住院医疗,包括普通病房、手术室、重症监护病房、复苏室和急诊科。
诊断标准与关键阈值
- 采用触发工具识别既往与类似事件相关的信息,并结合电子健康记录全面审查来评估围手术期住院不良事件。
- 不良事件分类为重大:导致需要重大干预或延长恢复的严重伤害、涉及危及生命的事件或导致死亡。
- 潜在可预防事件包括确定可预防、很可能可预防或可能可预防的事件。
研究设计与关键结果
- 多中心回顾性队列研究,纳入美国11家医院2018年因手术入院的1009例成人患者(随机抽取自64 121例)。
- 不良事件发生率为38.0%(95%CI 32.6–43.4),重大不良事件发生率为15.9%(95%CI 12.7–19.0)。
- 593起不良事件中,353起(59.5%)潜在可预防,123起(20.7%)为确定或很可能可预防。
- 最常见不良事件为手术操作相关(292起,49.3%),其次为药物不良事件(158起,26.6%)、医疗相关感染(74起,12.4%)、患者护理事件(66起,11.2%)和输血反应(3起,0.5%)。
- 不良事件最常见于普通病房(289起,48.8%),其次为手术室(155起,26.1%)、重症监护病房(77起,13.0%)、复苏室(20起,3.3%)、急诊科(11起,1.8%)和其他院内地点(42起,7.0%)。
- 涉及职业以主治医师最多(531起,89.5%),其次为护士(349起,58.9%)、住院医师(294起,49.5%)、高级执业人员(169起,28.5%)和专科培训医师(68起,11.5%)。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,研究结果强调围手术期全程所有卫生专业人员持续改进患者安全的必要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To estimate the frequency, severity, and preventability of adverse events associated with perioperative care, and to describe the setting and professions concerned.
DESIGN: Multicenter retrospective cohort study.
SETTING: 11 US hospitals.
PARTICIPANTS: 1009 patients from a randomly selected sample of 64 121 adults admitted for surgery during 2018.
MAIN OUTCOME MEASURES: Adverse events during inpatient perioperative care were assessed using a trigger method, identifying information previously associated with similar events, and from a comprehensive review of electronic health records. Trained nurses reviewed all records and flagged admissions with possible adverse events, which were then adjudicated by physicians, who confirmed the occurrence and characteristics of the events. Adverse events were classified as major if they resulted in serious harm requiring substantial intervention or prolonged recovery, involved a life threatening event, or led to a fatal outcome. Potentially preventable events included those definitively, probably, or possibly preventable.
RESULTS: Among 1009 patients reviewed, adverse events were identified in 38.0% (95% confidence interval 32.6 to 43.4), with major adverse events occurring in 15.9% (12.7 to 19.0). Of 593 identified adverse events, 353 (59.5%) were potentially preventable and 123 (20.7%) were definitely or probably preventable. The most common adverse events were related to surgical procedures (n=292, 49.3%), followed by adverse drug events (n=158, 26.6%), healthcare associated infections (n=74, 12.4%), patient care events (n=66, 11.2%), and blood transfusion reactions (n=3, 0.5%). Adverse events were most frequent in general care units (n=289, 48.8%), followed by operating rooms (n=155, 26.1%), intensive care units (n=77, 13.0%), recovery rooms (n=20, 3.3%), emergency departments (n=11, 1.8%), and other in-hospital locations (n=42, 7.0%). Professions most involved were attending physicians (n=531, 89.5%), followed by nurses (n=349, 58.9%), residents (n=294, 49.5%), advanced level practitioners (n=169, 28.5%), and fellows (n=68, 11.5%).
CONCLUSIONS: Adverse events were identified in more than one third of patients admitted to hospital for surgery, with nearly half of the events classified as major and most potentially preventable. These findings emphasize the critical need for ongoing improvement in patient safety, involving all health professionals, throughout perioperative care.
参考来源
- Duclos A, Frits ML, Iannaccone C, et al. Safety of inpatient care in surgical settings: cohort study. BMJ. 2024. PMID: 39537329. doi:10.1136/bmj-2024-080480
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。